Federal research funding now requires security vetting; early-stage startups face new barriers.

What it does

This bill extends the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs through 2031 and adds new security vetting requirements for small businesses receiving federal research awards. It creates a new "strategic breakthrough" funding track allowing up to $30 million per award for mature technologies with private matching funds, caps the number of proposals small businesses can submit annually to reduce administrative burden, and enhances training for federal contracting officers on Phase III commercialization awards.

Why we flagged it

The bill's primary function is reauthorizing and extending existing small-business research programs through 2031. The operative mechanism adds national-security vetting (foreign-entity screening, sanctioned-list checks) and creates a new high-value funding track for breakthrough technologies. Security screening is the novel substantive addition; extension of existing programs is routine.

What the text implies

• Security-risk determinations are discretionary and may lack transparent appeal processes; agencies have broad latitude to deny awards based on vague criteria like "any reason" or classified intelligence, potentially creating a chilling effect on foreign-born entrepreneurs or firms with international research collaborations.
• Strategic breakthrough allocation ($30M awards) requires 100% private matching funds and prior Phase II success, effectively reserving this accelerated track for well-capitalized, established firms—excluding early-stage innovators and startups without venture backing.
• Proposal-submission caps (with only 5% waiver allowance) may reduce competition and limit small businesses' ability to pursue multiple research directions, potentially concentrating awards among repeat applicants.
• GAO study period extended from 3 to 8 years, delaying independent evaluation of program effectiveness and security-vetting outcomes until 2030.
• Classified security-risk determinations (subsection (vv)(2)(E)) may prevent small businesses from understanding why they were denied, limiting their ability to remediate or challenge decisions.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill strengthens national-security vetting for federally funded research, which protects public interests in preventing technology transfer to adversaries. However, the security criteria are broad and discretionary ("any reason", "classified" sources, agency determination), potentially chilling legitimate small-business participation and innovation. The strategic-breakthrough track benefits only mature firms with private capital, excluding early-stage innovators. Proposal caps reduce adminis

Who stands to gain

• Small businesses with prior Phase II awards and private capital (strategic breakthrough track)
• Defense contractors and national-security-vetted firms (preferred access to accelerated funding)
• Federal agencies (reduced administrative burden from proposal caps)

Named in the bill

Small Business Administration (SBA), Department of Defense, Department of Energy, National Aeronautics and Space Administration (NASA), Department of Commerce (Bureau of Industry and Security), Department of Homeland Security, Department of the Treasury (OFAC), Federal Communications Commission (FCC), U.S. Customs and Border Protection, Intelligence Community, SBIR program, STTR program

Where it stands

1 cosponsor: 1 Democrats.

• Mar 3, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• Mar 3, 2026 — Passed the Senate · Congress.gov: “Passed/agreed to in Senate: Introduced in the Senate, read twice, considered, read the third time, and passed…”
• Mar 16, 2026 — Floor vote scheduled · Congress.gov: “Ms. Van Duyne moved to suspend the rules and pass the bill”
• Mar 17, 2026 — Passed both chambers · Congress.gov: “On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 345 - 41…”
• Apr 2, 2026 — Sent to president · Congress.gov: “Presented to President”
• Apr 13, 2026 — Signed into law · Congress.gov: “Became Public Law No: 119-83”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

14 lobbying clients named this bill on 15 disclosure filings across 2 quarters, Mar 2026 to Jun 2026. Those filings disclosed $41,040,892 in lobbying spend. A filing names 8 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 94% of bills with at least one filing.

Joni Ernst, the sponsor, reported $342,120 in PAC receipts in the 2026 cycle.

• Chamber of Commerce of the U.S.A. — $36,700,000 on 2 filings
• Biotechnology Innovation Organization — $2,360,000 on 1 filing
• Association of American Medical Colleges — $821,438 on 1 filing
• Aerospace Industries Association of America Inc — $800,000 on 1 filing
• The Ohio State University — $89,454 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.